Related Experiment Video
Updated: Feb 27, 2026
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle
Matthew N Bainbridge1, Erin Cooney2, Marcus Miller2
1Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, United States; Codified Genomics LLC, Houston, TX, United States; Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, United States.
Objective:
To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay.
Methods:
Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects.
Results:
Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain.
Significance:
Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.
